SA49 Virological Suppression in People Living with HIV-1 (PLWH) Receiving Dolutegravir/Lamivudine Was High and Similar across Age Groups Despite Older Plwh Having Increased Rates of Comorbidities and Polypharmacy (TANDEM SUBGROUP)
Jun 1, 2023, 00:00
10.1016/j.jval.2023.03.2265
https://www.valueinhealthjournal.com/article/S1098-3015(23)02365-3/fulltext
Title :
SA49 Virological Suppression in People Living with HIV-1 (PLWH) Receiving Dolutegravir/Lamivudine Was High and Similar across Age Groups Despite Older Plwh Having Increased Rates of Comorbidities and Polypharmacy (TANDEM SUBGROUP)
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(23)02365-3&doi=10.1016/j.jval.2023.03.2265
First page :
Section Title :
Open access? :
No
Section Order :
11588